Alzheimer’s Disease Epidemiology Quiz
9 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the approximate prevalence of moderate to severe Alzheimer's dementia in individuals over the age of 85?

  • 5%
  • 50%
  • 15%
  • 30% (correct)
  • Which of the following factors is NOT considered a risk factor for Alzheimer's disease?

  • Genetic predisposition
  • Environmental toxins (correct)
  • Trauma
  • Family history
  • Which area of the brain is primarily affected by the loss of cholinergic cells in Alzheimer's disease?

  • Medial septum (correct)
  • Cerebellum
  • Amygdala
  • Locus coeruleus
  • What pathological feature is most closely associated with the cognitive impairment severity in Alzheimer's disease?

    <p>Number of neurofibrillary tangles</p> Signup and view all the answers

    What genetic mutation is most commonly associated with early-onset familial Alzheimer's disease?

    <p>Presenilin-1 mutations on chromosome 14</p> Signup and view all the answers

    How does the incidence of Alzheimer's disease differ between genders?

    <p>It is more common in women than in men, with a ratio of 2:1.</p> Signup and view all the answers

    In Alzheimer's disease, the presence of which type of plaques is considered a critical pathological feature?

    <p>Amyloid plaques</p> Signup and view all the answers

    Which neurotransmitter's loss correlates with depression in Alzheimer's disease?

    <p>Noradrenaline</p> Signup and view all the answers

    What is one consequence of the presence of β-A4 amyloid in Alzheimer's disease?

    <p>Alters calcium homeostasis</p> Signup and view all the answers

    Study Notes

    Epidemiology of Alzheimer's Disease

    • Progressive neurodegenerative disorder primarily affecting older adults.
    • Prevalence of moderate to severe Alzheimer's dementia increases with age: ~5% in individuals over 65, ~30% for those over 85.
    • Affects women more frequently than men at a ratio of 2:1.
    • Disease progression varies and typically occurs slowly over time.

    Aetiology

    • Complex disorder with multiple contributing factors.
    • Trauma: Independent risk factor, especially in genetically predisposed individuals.
    • Genetic Factors:
      • Family history is a strong risk factor; familial forms are autosomal dominant.
      • Chromosome 14 mutations related to early-onset familial Alzheimer's.
      • Apolipoprotein ε gene (chromosome 19) linked to late-onset Alzheimer's; ε4-ε4 genotype increases risk.
    • Molecular Genetics:
      • β-amyloid precursor protein gene mutations on chromosome 21 cause early-onset in Down's syndrome.
      • Early-onset familial Alzheimer's primarily associated with specific chromosomal mutations.

    Patterns of Onset and Gene Implications

    • Early-Onset:
      • Presenilin-1 (chromosome 14) causes about 50% of early cases.
      • Presenilin-2 has 2 known mutations (chromosome 1).
      • Amyloid Precursor Protein (chromosome 21) is a rare cause.
    • Late-Onset:
      • Apolipoprotein ε4 found on chromosome 19 affects onset age.

    Pathology

    • Reduction in cortical volume and subcortical white matter leads to dilation of cortical spaces and enlarged lateral ventricles.
    • Loss of cortical neurons affects outer layers of the cortex, hippocampus, and parietal regions.
    • Visuosensory and sensorimotor areas are relatively preserved until late stages.
    • Cognitive impairment severity correlates with synapse loss and presence of:
      • Amyloid Plaques: Composed of β-A4 peptide; found in temporal cortex, amygdala, and hippocampus.
      • Neurofibrillary Tangles: Result from tau protein phosphorylation; correlate with cognitive impairment, particularly prominent in the neocortex.
    • Other features include gliosis, granulovacuolar degeneration, Hirano bodies, and amyloid angiopathy.

    Neurochemistry

    • Cholinergic Loss:
      • Significant depletion of choline acetyltransferase (ChAT) and acetylcholine in the temporal cortex.
      • Cholinomimetics may improve cognitive deficits.
    • Noradrenergic Loss:
      • Reduced noradrenaline levels in cortex and hippocampus; correlates with early onset Alzheimer's-related depression.
    • Serotonergic Loss:
      • Loss of 5-HT2 receptors in frontal and temporal lobes.
    • Other biochemical changes include:
      • Abnormal β-A4 amyloid altering calcium homeostasis and increasing neuronal susceptibility to excitotoxicity.
      • Decreased levels of GABA, somatostatin, and mitochondrial complexes which may reflect reduced cholinergic activity.
      • An increase in morning growth hormone levels noted in some forms of Alzheimer's.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on the epidemiology of Alzheimer's disease, a neurodegenerative disorder that predominantly affects older adults. This quiz covers prevalence rates, gender differences, and age-related statistics associated with the condition. Challenge yourself with relevant questions based on current research findings.

    More Like This

    Use Quizgecko on...
    Browser
    Browser